Home >> DNA Damage >> HDAC >>

HDAC Inhibitors

Cat.No. Product Name Information Publication Customer Review
S1053 Entinostat (MS-275, SNDX-275) MS-275 is an HDAC inhibitor of HDAC1 and HDAC3 with IC50 of 0.51 μM and 1.7 μM, respectively. (17)
S1030 Panobinostat (LBH589) LBH589 (Panobinostat) is a novel broad-spectrum HDAC inhibitor with IC50 of 5 nM and 20 nM in MOLT-4 and Reh cells, respectively. (10)
S1045 Trichostatin A (TSA) Trichostatin A (TSA) is an HDAC inhibitor with IC50 of ~1.8 nM. (1)
S1122 Mocetinostat (MGCD0103) MGCD0103 (Mocetinostat) is a potent HDAC inhibitor for HDAC1, HDAC2 and HDAC3 with IC50 of 0.15 μM, 0.29 μM and 1.66 μM, respectively. (9)
S2627 Tubastatin A HCl Tubastatin A is a potent HDAC6 inhibitor with IC50 of 15 nM.
S1085 Belinostat (PXD101) Belinostat (PXD101) is a novel HDAC inhibitor with IC50 of 27 nM in HeLa cell extracts. (3)
S2170 ITF2357 (Givinostat) ITF2357 (Givinostat) is a potent inhibitor of HDAC with IC50 of 7.5-16 nM.
S8043 Scriptaid Scriptaid is an inhibitor of HDAC.
S8049 Tubastatin A Tubastatin A is a potent and selective inhibitor of HDAC6 with IC50 of 15 nM.
S4909 Apicidin (OSI-2040) Apicidin is a potent HDAC inhibitor with IC50 of 0.7 nM.
S8001 Rocilinostat (ACY-1215) Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM.
S2779 M344 M344 is a potent HDAC inhibitor with IC50 of 100 nM.
S2759 PI3K/HDAC InhibitorⅠ PI3K/HDAC Inhibitor I is a dual PI3K and HDAC inhibitor for PI3Kɑ, HDAC1, HDAC2, HDAC3 and HDAC10 with IC50 of 19 nM, 1.7 nM, 5 nM, 1.8 nM and 2.8 nM, respectively.
S2012 PCI-34051 PCI-34051 is a potent and specific HDAC8 inhibitor with IC50 of 10 nM.
S2818 CI994 (Tacedinaline) CI994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.57 μM.
S2244 AR-42 (HDAC-42) AR-42 (HDAC-42, OSU-HDAC42) is a pan-HDAC inhibitor with IC50 30 nM.
S1515 SB939 (Pracinostat) SB939 is a potent HDAC inhibitor with IC50 of 40-140 nM. (1)
S1484 MC1568 MC1568 is a selective HDAC inhibitor with IC50 of 220 nM. (6)
S1422 Droxinostat Droxinostat (CMH, 5809354) is a selective inhibitor of HDAC3, HDAC6 and HDAC8 with IC50 of 16.9 μM, 2.47μM and 1.46 μM, respectively. (1)
S1194 CUDC-101 CUDC-101 is a potent multi-target inhibitor targeting HDAC, EGFR and HER2 with IC50 of 4.4 nM, 2.4 nM, and 15.7 nM, respectively.
S1096 JNJ-26481585 JNJ-26481585 (Quisinostat) is an HDAC inhibitor for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11 with IC50 of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM and 0.37 nM, respectively.
S1095 LAQ824 (NVP-LAQ824, Dacinostat) LAQ824 (NVP-LAQ824) is a novel HDAC inhibitor with IC50 of 32 nM. (3)
S1090 PCI-24781 PCI-24781 (CRA-024781) is a novel broad spectrum HDAC inhibitor targeting HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 and HDAC10 with Ki of 7 nM, 19 nM, 8.2 nM, 17 nM, 280 nM, 24 nM, respectively. (1)